NIMH Chemical Synthesis and Drug Supply Program

Compound Information Page

Compound Name: N-benzo[1,3]dioxol-5-yl-2-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H purin-8-yl)-1-methyl- 1H-pyrazol-3-yloxy]acetamide (MRE 2029-F20)
NIMH Code: B-907
Alternative Name: MRE 2029-F20
Abbreviation:
Indications: A2B adenosine receptor antagonist.
Package Sizes:
References: Baraldi, P. G.; Tabrizi, M. A.; Preti, D.; Bovero, A.; Romagnoli, R.; Fruttarolo, F.; Zaid, N. A.; Moorman, A. R.; Varani, K.; Gessi, S.; Merighi, S.; Borea, P. A. J. Med. Chem. 2004, 47, 1434-1447.
CAS:
Molecular Formula:
HBA:
HBD:
RotB:
PubChemID:
AlogP:
TPSA:
Activity:
Comments:
Last Updated 2012-01-31 04:15 PM
Structure of B-907
About The Program

Since 1959, the NIMH Chemical Synthesis and Drug Supply Program has synthesized and distributed novel research chemicals, psychoactive drugs, and compounds that are unavailable from commercial sources to the scientific community working on research relevant to mental health.

Content © 2014. «RTI International».